HealthEquity Beats Q2 with EPS $0.78 and GF Score 96; Best Buy Tops with EPS $1.48

The Quick Take

• HealthEquity beat Q2 with EPS $0.78 and revenue $350.7M, earning a near-perfect GF Score of 96/100
• Best Buy also beat Q2 with EPS $1.48 and revenue $9.779B but trades at an estimated 149% overvaluation
• HSA asset growth and consumer electronics demand both demonstrated resilience in the quarter

Two companies from distinct sectors reported second-quarter earnings beats on August 27, 2026. HealthEquity, a health savings account administrator, posted diluted EPS of $0.78, exceeding analyst expectations, with revenue of $350.7 million and a GF Score of 96 out of 100 reflecting strong fundamental quality. Best Buy, the consumer electronics retailer, also beat Q2 expectations with EPS of $1.48 and revenue of $9.779 billion, though GurFocus analysis placed the stock at approximately 149 percent overvaluation relative to its intrinsic value estimate, assigning a GF Score of 75. Both results demonstrate earnings resilience across different areas of the consumer and healthcare economy.

HealthEquity's GF Score of 96 reflects excellent marks across growth, profitability, financial strength, and momentum metrics, making it one of the highest-quality companies in the healthcare administration sector. HSA assets under management continue to grow as healthcare consumers increasingly save for medical expenses in tax-advantaged accounts, providing HealthEquity with a recurring revenue stream that compounds over time as account holders accumulate balances. The Q2 beat suggests the company's custodian fee income and investment income from HSA assets exceeded expectations, driven by higher average account balances and favorable interest rate conditions on invested assets.

Best Buy's Q2 results show consumer electronics demand has held up better than feared, despite concerns about a cyclical spending pullback. Revenue of $9.779 billion suggests the company benefited from product refresh cycles, particularly in AI-integrated laptops and home appliances. The GurFocus overvaluation flag of 149 percent warrants caution for value-oriented investors, even as the earnings beat demonstrates operational resilience. Retail investors tend to reward beats with immediate price appreciation, but fundamental valuation concerns can limit longer-term upside. The divergence between HealthEquity's strong quality metrics and Best Buy's elevated valuation illustrates how earnings beats alone do not determine investment attractiveness.

Synthesized from 1 source(s).